Cervical Intraepithelial Neoplasia

Overview

Journal J Clin Pathol

Specialty Pathology

Date 1982 Jan 1

PMID 7037858

Citations 68

Authors

C H Buckley

E B Butler

H Fox

Affiliations

Soon will be listed here.

Abstract

The theoretical and practical reasons for replacing the terms "cervical dysplasia" and "cervical carcinoma in situ" by the single diagnostic entity of "cervical intraepithelial neoplasia" are reviewed and the advantages and drawbacks of this newer terminology discussed. The histological characteristics and cytological features of the various grades of cervical intraepithelial neoplasia are described and the differential diagnosis of this lesion is considered.

Citing Articles

Pioneering molecular screening for cervical precursor lesions and cervical cancer in sera.

Miranda-Falconi P, Flores-Pena G, Jimenez-Trejo M, Torres-Paz Y, Reyes-Hernandez D, Estrada-Guzman J Front Oncol. 2024; 14:1483882.

PMID: 39610929 PMC: 11602649. DOI: 10.3389/fonc.2024.1483882.

Altered mitochondrial DNA copy number in cervical exfoliated cells among high‑risk HPV‑positive and HPV‑negative women.

Al-Awadhi R, AlRoomy M, Al-Waheeb S, Alwehaidah M Exp Ther Med. 2023; 26(5):521.

PMID: 37854504 PMC: 10580246. DOI: 10.3892/etm.2023.12220.

Androgen promotes squamous differentiation of atypical cells in cervical intraepithelial neoplasia via an ELF3-dependent pathway.

Matsumoto T, Suzuki T, Nakamura M, Yamamoto M, Iizuka T, Ono M Cancer Med. 2023; 12(9):10816-10828.

PMID: 36951594 PMC: 10225190. DOI: 10.1002/cam4.5824.

Evaluation of HPV E6/E7 mRNA Detection in Clinically Suspected Cases of Cervical Cancer with Abnormal Cytology: Time to Upgrade the Screening Protocols.

Sharma B, Lakhanpal V, Singh K, Oberoi L, Bedi P, Devi P J Lab Physicians. 2022; 14(3):336-342.

PMID: 36119422 PMC: 9473935. DOI: 10.1055/s-0042-1748919.

FOXP4 inhibits squamous differentiation of atypical cells in cervical intraepithelial neoplasia via an ELF3-dependent pathway.

Matsumoto T, Iizuka T, Nakamura M, Suzuki T, Yamamoto M, Ono M Cancer Sci. 2022; 113(10):3376-3389.

PMID: 35838233 PMC: 9530870. DOI: 10.1111/cas.15489.

References

Wilbanks G, Richart R, TERNER J . DNA content of cervical intraepithelial neoplasia studied by two-wavelength Feulgen cytophotometry. Am J Obstet Gynecol. 1967; 98(6):792-9. DOI: 10.1016/0002-9378(67)90195-0. View

Richart R, LERCH V, Barron B . A time-lapse cinematographic study in vitro of mitosis in normal human cervical epithelium, dysplasia, and carcinoma in situ. J Natl Cancer Inst. 1967; 39(3):571-7. View

KIRKLAND J, Stanley M, Cellier K . Comparative study of histologic and chromosomal abnormalities in cervical neoplasia. Cancer. 1967; 20(11):1934-52. DOI: 10.1002/1097-0142(196711)20:11<1934::aid-cncr2820201122>3.0.co;2-4. View

FIDLER H, Boyes D, Worth A . Cervical cancer detection in British Columbia. A progress report. J Obstet Gynaecol Br Commonw. 1968; 75(4):392-404. DOI: 10.1111/j.1471-0528.1968.tb00136.x. View

SHINGLETON H, Richart R, Wiener J, SPIRO D . Human cervical intraepithelial neoplasia: fine structure of dysplasia and carcinoma in situ. Cancer Res. 1968; 28(4):695-706. View

Kaufman R . Dysplasia and carcinoma in situ of the cervix. Clin Obstet Gynecol. 1967; 10(4):748-84. View

Cocker J, Fox H, Langley F . Consistency in the histological diagnosis of epithelial abnormalities of the cervix uteri. J Clin Pathol. 1968; 21(1):67-70. PMC: 473666. DOI: 10.1136/jcp.21.1.67. View

Govan A, HAINES R, Langley F, Taylor C, WOODCOCK A . The histology and cytology of changes in the epithelium of the cervix uteri. J Clin Pathol. 1969; 22(4):383-95. PMC: 474187. DOI: 10.1136/jcp.22.4.383. View

Richart R, Barron B . A follow-up study of patients with cervical dysplasia. Am J Obstet Gynecol. 1969; 105(3):386-93. DOI: 10.1016/0002-9378(69)90268-3. View

10.

Spriggs A, Bowey C, Cowdell R . Chromosomes of precancerous lesions of thecervix uteri. New data and a review. Cancer. 1971; 27(5):1239-54. DOI: 10.1002/1097-0142(197105)27:5<1239::aid-cncr2820270532>3.0.co;2-v. View

11.

Richart R . Cervical intraepithelial neoplasia. Pathol Annu. 1973; 8:301-28. View

12.

Husain O, Butler E, Evans D, Macgregor J, Yule R . Quality control in cervical cytology. J Clin Pathol. 1974; 27(12):935-44. PMC: 475559. DOI: 10.1136/jcp.27.12.935. View

13.

Roche W, NORRIS H . Microinvasive carcinoma of the cervix. The significance of lymphatic invasion and confluent patterns of stromal growth. Cancer. 1975; 36(1):180-6. DOI: 10.1002/1097-0142(197507)36:1<180::aid-cncr2820360116>3.0.co;2-k. View

14.

BURGHARDT E . Premalignant conditions of the cervix. Clin Obstet Gynaecol. 1976; 3(2):257-94. View

15.

Koss L . Dysplasia. A real concept or a misnomer?. Obstet Gynecol. 1978; 51(3):374-9. View

16.

Riddell R, Shove D, Ritchie J, Lennard-Jones J, MORSON B . Precancer in ulcerative colitis. Major Probl Pathol. 1978; 10:95-118. View

17.

Gupta P, Burroughs F, Luff R, FROST J, Erozan Y . Epithelial atypias associated with intrauterine contraceptive devices (IUD). Acta Cytol. 1978; 22(5):286-91. View

18.

Briggs R . Dysplasia and early neoplasia of the uterine cervix. A review. Obstet Gynecol Surv. 1979; 34(1):70-99. View

19.

NELSON Jr J, AVERETTE H, Richart R . Detection, diagnostic evaluation and treatment of dysplasia, carcinoma in situ and early invasive cervical carcinoma. CA Cancer J Clin. 1979; 29(3):174-92. DOI: 10.3322/canjclin.29.3.174. View

20.

Richart R . Current concepts in obstetrics and gynecology: The patient with an abnormal Pap smear--screening techniques and management. N Engl J Med. 1980; 302(6):332-4. DOI: 10.1056/NEJM198002073020606. View